Quantum Pharma Plc (LSE: QP)[3] is a manufacturer and supplier of unlicensed medicines and Special Obtain products based in Burnopfield, County Durham.

[3][2] The IPO was done on the Alternative Investment Market (AIM) on the London Stock Exchange, and the Nominated Advisor for the company's offering was Zeus Capital.

[3] Funds from the IPO went to finalizing acquisition of Colonis Pharma Limited and paying off outstanding business debt.

[7][8] In June 2013 the Daily Telegraph infiltrated reporters into the annual Pharmacy Congress to investigate malpractice in the market for Specials.

In December 2013 it was fined more than £380,000 by the Office of Fair Trading over a cartel arrangement in which it carved up some of a multimillion-pound market in prescription drugs for care homes with Lloyds Pharmacy.